BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Donati M, Stang A, Stavrou GA, Basile F, Oldhafer KJ. Extending resectability of hilar cholangiocarcinomas: how can it be assessed and improved? Future Oncol 2019;15:193-205. [PMID: 30378439 DOI: 10.2217/fon-2018-0413] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Nanashima A, Tanoue Y, Sakae T, Tsuneyoshi I, Hiyoshi M, Imamura N, Hamada T, Yano K, Nishida T, Ishii M, Nagayasu T, Nakamura K. Relationship between hepatic venous anatomy and hepatic venous blood loss during hepatectomy. Surg Today 2021. [PMID: 34129114 DOI: 10.1007/s00595-021-02314-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Passeri MJ, Baimas-George MR, Sulzer JK, Iannitti DA, Martinie JB, Baker EH, Ocuin LM, Vrochides D. Prognostic impact of the Bismuth-Corlette classification: Higher rates of local unresectability in stage IIIb hilar cholangiocarcinoma. Hepatobiliary Pancreat Dis Int 2020;19:157-62. [PMID: 32088126 DOI: 10.1016/j.hbpd.2020.02.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Donati M, Zanatta M, Basile F. Is the Bismuth-Corlette IIIb stage really an unfavorable situation for resectability of Klatskin tumors? A critical appraisal. Hepatobiliary Pancreat Dis Int 2020;19:505-6. [PMID: 32859506 DOI: 10.1016/j.hbpd.2020.08.006] [Reference Citation Analysis]
4 Köhler M, Harders F, Lohöfer F, Paprottka PM, Schaarschmidt BM, Theysohn J, Herrmann K, Heindel W, Schmidt HH, Pascher A, Stegger L, Rahbar K, Wildgruber M. Prognostic Factors for Overall Survival in Advanced Intrahepatic Cholangiocarcinoma Treated with Yttrium-90 Radioembolization. J Clin Med 2019;9:E56. [PMID: 31881761 DOI: 10.3390/jcm9010056] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
5 Feng Y, Bai Z, Song J, Zhang Z. FOXK1 plays an oncogenic role in the progression of hilar cholangiocarcinoma. Mol Med Rep 2021;23:91. [PMID: 33300075 DOI: 10.3892/mmr.2020.11730] [Reference Citation Analysis]